{
    "title": "103_s1249",
    "content": "The Act may be cited as the \"Tuberculosis Prevention and Control Amendments of 1993\". Between 10-15 million people in the US have tuberculosis, with 26,000 new cases and 1,700 deaths annually. Reported cases have increased, with drug-resistant strains costing over $150,000 to treat. In 1992, all 50 states reported tuberculosis cases to the CDC. In 1992, drug-resistant tuberculosis strains cost over $150,000 to treat, with a high mortality rate. Tuberculosis cases were reported in all 50 states, with drug-resistant cases in at least 36 states. 27% of cases in 1992 were in foreign-born individuals. Tuberculosis affects one third of the world's population and remains the number one killer among infectious diseases, with 8 million new cases and 2.9 million deaths annually. SEC. 3. PROGRAMS OF CENTERS FOR DISEASE CONTROL AND PREVENTION. The amendment to the Public Health Service Act allocates funding for tuberculosis prevention, control, and elimination services for fiscal years 1994 through 1997. States applying for grants must submit a plan demonstrating how the funds will be used to provide tuberculosis services. The amendment to the Public Health Service Act allocates funding for tuberculosis prevention, control, and elimination services. States applying for grants must submit a plan demonstrating how funds will be used to provide tuberculosis services to high-risk individuals or areas with high infection rates. Plans must also show collaboration with entities receiving funds under various sections and use of grant funds for effective interventions. The amendment to the Public Health Service Act requires states to demonstrate in their grant plans how funds will be used for tuberculosis services in high-risk populations. Collaboration with entities receiving funds under specific sections is necessary, and grant funds must be used for effective interventions. The Public Health Service Act is amended to support grants for tuberculosis research, training, prevention, and treatment. $26,000,000 is authorized for fiscal year 1994, with additional funding for subsequent years. Collaboration with grant recipients is required for effective interventions in high-risk populations. The Public Health Service Act authorizes $26,000,000 for tuberculosis research, training, prevention, and treatment for fiscal year 1994, with additional funding for subsequent years. Amendments include collaboration with grant recipients for interventions in high-risk populations. The Public Health Service Act authorizes funding for tuberculosis research, training, prevention, and treatment. An amendment includes collaboration with grant recipients for interventions in high-risk populations. Additionally, research and research training regarding tuberculosis are emphasized through the National Institute of Allergy and Infectious Diseases. The Public Health Service Act authorizes funding for tuberculosis research, training, prevention, and treatment through the National Institute of Allergy and Infectious Diseases. Section 447 focuses on basic research and research training for the cause, diagnosis, early detection, and treatment of tuberculosis. Authorization of appropriations includes $46,000,000 for fiscal year 1994 for this purpose. The Health Service Act is amended to authorize $46,000,000 for tuberculosis research through the National Institute on Allergy and Infectious Diseases for fiscal year 1994, with additional funding for the following years. This does not affect any other authorization of appropriations for the same purpose. The Food, Drug and Cosmetic Act is amended to establish a tuberculosis drug and device research program under the FDA. The program includes providing assistance for tuberculosis protocols, reviewing medical devices for tuberculosis diagnosis, and conducting research on drugs and devices for tuberculosis control. $5,000,000 is authorized annually for this program."
}